BlackRock, Inc. 13D and 13G filings for Reata Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
BlackRock Inc. BLK |
2,501,693 7.900% |
387,643 (+18.34%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA |
BlackRock Inc. BLK |
2,114,050 6.700% |
737,966 (+53.63%) |
Filing |
| 2020-10-09 09:14 am Sale |
2020-09-30 | 13G | Reata Pharmaceuticals, Inc. RETA |
BlackRock Inc. BLK |
1,376,084 4.800% |
-867,787 (-38.67%) |
Filing |